Thermo Fisher Scientific (TMO) Other Non Operating Income (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Other Non Operating Income for 18 consecutive years, with $31.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non Operating Income rose 263.16% year-over-year to $31.0 million; the trailing twelve-month figure through Jun 2026 stood at $26.0 million (up 244.44% YoY), and the FY2025 full-year result was -$12.0 million, down 200.0% from the prior year.
• Other Non Operating Income rose to $31.0 million in Q2 2026 per TMO's latest filing, from -$9.0 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $35.0 million in Q4 2022 and bottomed at -$163.0 million in Q2 2022.
• Historically, Other Non Operating Income has averaged -$8.6 million across 5 years, with a median of $3.0 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Other Non Operating Income soared 1033.33% in 2022, then sank 480.0% in 2025.
• Over 5 years, Other Non Operating Income stood at $35.0 million in 2022, then tumbled by 194.29% to -$33.0 million in 2023, then soared by 142.42% to $14.0 million in 2024, then tumbled by 57.14% to $6.0 million in 2025, then jumped by 416.67% to $31.0 million in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered $31.0 million, -$9.0 million, and $6.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.